1.11.1.27: glutathione-dependent peroxiredoxin

This is an abbreviated version!
For detailed information about glutathione-dependent peroxiredoxin, go to the full flat file.

Reaction

2 glutathione +

Synonyms

1-Cys peroxiredoxin, 1-Cys Prdx, 1-Cys Prx, 1-CysPrx, 2-Cys peroxiredoxin, 2-Cys peroxiredoxin TPx-1, EC 1.11.1.15, glutathione peroxidase, GPX, HI0572, peroxiredoxin 6, peroxiredoxin II, peroxiredoxin VI, Pf1-Cys-Prx, PGdx, Prdx6, Prx1, Prx3, Prx6, TPx-1

ECTree

     1 Oxidoreductases

         1.11 Acting on a peroxide as acceptor

             1.11.1 Peroxidases

                1.11.1.27 glutathione-dependent peroxiredoxin

Advanced search results

Do not include text mining results

Include results (more...)

Include results (more...)

Results	in table
1	Activating Compound
10172	AA Sequence
1	Application
15	Cloned(Commentary)
2	Crystallization (Commentary)
16	Disease/ Diagnostics
9	Expression
25	General Information
1	General Stability
1	IC50 Value
13	Inhibitors
2	kcat/KM [mM/s]
9	KM Value [mM]
12	Localization
10	Molecular Weight [Da]
22	Natural Substrates/ Products (Substrates)
34	Organism
2	Pathway
1	pH Optimum
1	pH Range
1	pH Stability
1	pI Value
5	Posttranslational Modification
12	Protein Variants
11	Purification (Commentary)
1	Reaction
34	Reference
44	Source Tissue
7	Specific Activity [micromol/min/mg]
57	Substrates and Products (Substrate)
14	Subunits
71	Synonyms
1	Systematic Name
2	Temperature Stability [°C]

Disease

topprint

print visible entries

print all entries

Disease on EC 1.11.1.27 - glutathione-dependent peroxiredoxin

Please use the Disease Search for a specific query.

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.

Please wait a moment until the data is sorted. This message will disappear when the data is sorted.

DISEASE

TITLE OF PUBLICATION

LINK TO PUBMED

Carcinoma

Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.

17085654

Esophageal Squamous Cell Carcinoma

Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma.

17085654

Hypersensitivity

2-Cys peroxiredoxin of Plasmodium falciparum is involved in resistance to heat stress of the parasite.

23201565

Lymphoma, B-Cell

High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index.

25935550

Lymphoma, Large B-Cell, Diffuse

High intensity of cytoplasmic peroxiredoxin VI expression is associated with adverse outcome in diffuse large B-cell lymphoma independently of International Prognostic Index.

25935550

html completed